| Literature DB >> 26424311 |
Natsumi Furuta1, Kunihiko Ishizawa, Makoto Shibata, Setsuki Tsukagoshi, Shun Nagamine, Kouki Makioka, Yukio Fujita, Masaki Ikeda, Shunsuke Yoshimura, Masakatsu Motomura, Koichi Okamoto, Yoshio Ikeda.
Abstract
We herein investigated the clinical features of three patients with anti-muscle-specific tyrosine kinase (MuSK) antibody-positive myasthenia gravis (MG), which was initially difficult to distinguish from amyotrophic lateral sclerosis (ALS). The patients exhibited dropped head syndrome or dysphagia as initial symptoms. Although their clinical findings were compatible with the revised El Escorial Criteria for ALS, their progression appeared to be more rapid than that of ALS. Both the edrophonium and repetitive nerve stimulation tests yielded negative results, and diurnal fluctuation was not confirmed. The patients were ultimately diagnosed with anti-MuSK antibody-positive MG. We therefore recommend the measurement of anti-MuSK antibodies when encountering such cases.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26424311 DOI: 10.2169/internalmedicine.54.4645
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271